MobiHealth News February 12, 2024
Also, SELVAS Healthcare will be bringing to South Korea a foreign contender to the booming AI-based medical imaging market.
Neurophet AI to integrate with upcoming Alzheimer’s treatment device
Neurophet has entered into a partnership with ReadyCure for the development of a dementia treatment system called Helaxon.
Based on a press statement, Neurophet will be integrating its AI solution, Neurophet AQUA, to support brain image analysis in Helaxon. The AI-based software can analyse and detect white matter degeneration in brain MRI scans of patients with Alzheimer’s disease.
ReadyCure will use this capability alongside its use of digital X-ray to deliver low-dose radiation to treat dementia, particularly Alzheimer’s disease.
New cardiac ultrasound AI coming to Korea
Digital health company...
Today's Sponsors
Today's Sponsor